These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 39007267)

  • 41. Wilms' tumour 1-associating protein inhibits endothelial cell angiogenesis by m6A-dependent epigenetic silencing of desmoplakin in brain arteriovenous malformation.
    Wang LJ; Xue Y; Li H; Huo R; Yan Z; Wang J; Xu H; Wang J; Cao Y; Zhao JZ
    J Cell Mol Med; 2020 May; 24(9):4981-4991. PubMed ID: 32281240
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic analysis of N6-methyladenosine modification genes in Parkinson's disease.
    Qin L; Min S; Shu L; Pan H; Zhong J; Guo J; Sun Q; Yan X; Chen C; Tang B; Xu Q
    Neurobiol Aging; 2020 Sep; 93():143.e9-143.e13. PubMed ID: 32371107
    [TBL] [Abstract][Full Text] [Related]  

  • 43. WTAP regulates autophagy in colon cancer cells by inhibiting FLNA through N6-methyladenosine.
    Huang L; Shao J; Xu X; Hong W; Yu W; Zheng S; Ge X
    Cell Adh Migr; 2023 Dec; 17(1):1-13. PubMed ID: 36849408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. WTAP-Mediated m6A RNA Methylation Regulates the Differentiation of Bone Marrow Mesenchymal Stem Cells via the miR-29b-3p/HDAC4 Axis.
    Liu J; You Y; Sun Z; Zhang L; Li X; Dai Z; Ma J; Chen Y; Jiao G
    Stem Cells Transl Med; 2023 May; 12(5):307-321. PubMed ID: 37010483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Marrow mesenchymal stem cell mediates diabetic nephropathy progression via modulation of Smad2/3/WTAP/m6A/ENO1 axis.
    Bai Y; Huang L; Fan Y; Li Y
    FASEB J; 2024 Jun; 38(11):e23729. PubMed ID: 38847786
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploration of the potential roles of m6A regulators in the uterus in pregnancy and infertility.
    Zhao S; Lu J; Chen Y; Wang Z; Cao J; Dong Y
    J Reprod Immunol; 2021 Aug; 146():103341. PubMed ID: 34116483
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Potential impact of WTAP and YTHDF2 on tumor immunity in lung adenocarcinoma.
    Zhang X; Cai X
    Medicine (Baltimore); 2022 Nov; 101(45):e31195. PubMed ID: 36397411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. WTAP mediates the anti-inflammatory effect of
    Long H; Lin H; Zheng P; Hou L; Zhang M; Lin S; Yin K; Zhao G
    Front Pharmacol; 2022; 13():1023878. PubMed ID: 36278233
    [No Abstract]   [Full Text] [Related]  

  • 49. Wilms' tumor 1-associating protein contributes to psoriasis by promoting keratinocytes proliferation via regulating cyclinA2 and CDK2.
    Kong Y; Wu R; Zhang S; Zhao M; Wu H; Lu Q; Fu S; Su Y
    Int Immunopharmacol; 2020 Nov; 88():106918. PubMed ID: 32866786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells.
    Feng Z; Li Q; Meng R; Yi B; Xu Q
    J Cell Mol Med; 2018 May; 22(5):2558-2568. PubMed ID: 29502358
    [TBL] [Abstract][Full Text] [Related]  

  • 51. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
    Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
    FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular mechanism of Wilms tumour 1-associated protein in diabetes-related dry eye disease by mediating m6A methylation modification of lncRNA NEAT1.
    Guo C; Yu M; Liu J; Jia Z; Liu H; Zhao S
    J Drug Target; 2024 Dec; 32(2):200-212. PubMed ID: 38153328
    [No Abstract]   [Full Text] [Related]  

  • 53. WTAP-mediated m6A modification on circCMTM3 inhibits hepatocellular carcinoma ferroptosis by recruiting IGF2BP1 to increase PARK7 stability.
    Chen S; Xia H; Sheng L
    Dig Liver Dis; 2023 Jul; 55(7):967-981. PubMed ID: 36586770
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Methyltransferase WTAP aggravates hypoxia/reoxygenation-induced myocardial cell injury by regulating the expression of activator of transcription 4].
    Yang N; Cao M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2024 Mar; 36(3):279-285. PubMed ID: 38538357
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Deng J; Zhang J; Ye Y; Liu K; Zeng L; Huang J; Pan L; Li M; Bai R; Zhuang L; Huang X; Wu G; Wei L; Zheng Y; Su J; Zhang S; Chen R; Lin D; Zheng J
    Cancer Res; 2021 Oct; 81(20):5268-5283. PubMed ID: 34362795
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EGR2-mediated regulation of m
    Ying Y; Ma X; Fang J; Chen S; Wang W; Li J; Xie H; Wu J; Xie B; Liu B; Wang X; Zheng X; Xie L
    Cell Death Dis; 2021 Jul; 12(8):750. PubMed ID: 34326314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. m6A Regulators in Human Adipose Tissue - Depot-Specificity and Correlation With Obesity.
    Rønningen T; Dahl MB; Valderhaug TG; Cayir A; Keller M; Tönjes A; Blüher M; Böttcher Y
    Front Endocrinol (Lausanne); 2021; 12():778875. PubMed ID: 34950106
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. WTAP-mediated m6A modification of IFNE is required for antiviral defense in condyloma acuminata.
    Gu Z; Liu J; Qin L; Zhang Y; Cui W; Huang H; Liu L; Cao Y; Zhang H
    J Dermatol Sci; 2023 Aug; 111(2):43-51. PubMed ID: 37516644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N
    Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
    Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.